Compound ID | 591
Class: Antivirulence agent (two-component system inhibitor)
| Spectrum of activity: | Gram-positive |
| Details of activity: | Potent activity against multidrug resistant S. aureus and E. faecium |
| Description: | Melton JL, Fernandez JA, Frechette RF, et al. In vivo activity of a novel series of antibacterial agents that inhibit the bacterial two component signal transduction system. 37th-Intersci-Conf-Antimicrobial-Agents-Chemother 1997; 185. |
| Institute where first reported: | Johnson & Johnson Pharmaceutical R&D, USA |
| Year first mentioned: | 1997 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Provided no protection to mice |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: |